E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest

Current Biology

Volumn 6, Issue 4, 1996, Pages 474-483

  Mann, David J ^a   Jones, Nic C ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; E2F4 PROTEIN, HUMAN; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN KINASE INHIBITOR; PROTEIN P16INK4A; RETINOBLASTOMA BINDING PROTEIN 1; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4;

ARTICLE; CELL CULTURE; CELL CYCLE G1 PHASE; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION;

BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; G1 PHASE; HUMANS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030113694     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00515-8     Document Type: Article

References (67)

1. Sherr CJ: Mammalian G1 cyclins. Cell 1993, 73:1059-1065.
2. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
3. Kato JY, Matsushime H, Heibert S, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4. Genes Dev 1993, 7:331-342.
4. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY, Livingstone DM: Functional interactions of the retinoblastoma protein with mammalian G1 cyclins. Cell 1993, 73: 487-497.
5. Chellappan S, Heibert S, Mudryji M, Horowitz JM, Nevins JR: The E2F transcription factor is a cellular target for the Rb protein. Cell 1991, 65:1053-1061.
6. Helin K, Lees JA, Vidal N, Dyson N, Harlow E, Fattaey AR: A cDNA encoding a pRb binding protein with the properties of transcription factor E2F. Cell 1992, 70:337-350.
7. Hamel PA, Gill RM, Phillips RA, Gallie BL: Transcriptional repression of the E2-containing promoters EllaE, c-myc and RB1 by the product of the RB1 gene. Mol Cell Biol 1992, 12:3431-3438.
8. Heibert SW, Chellappan SP, Horowitz JM, Nevins JR: The interaction of pRb and E2F inhibits the transcriptional activity of E2F. Genes Dev 1992, 6:177-185.
9. Zamanian M, La Thangue NB: Adenovirus E1A prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 1992, 11:2603-2610.
10. Helin K, Harlow E, Fattaey AR: Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993, 13:6501-6508.
11. Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424-429.
12. Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees JA: In vivo association of E2F and DP family proteins. Mol Cell Biol 1995, 15:2536-2546.
13. Huber HE, Edwards G, Goodhart PJ, Patrick DR, Huang PS, Ivey-Hoyle M, et al.: Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci USA 1993, 90:3525-3529.
14. Zhang Y, Chellappan S: Cloning and characterisation of human DP-2, a novel dimerisation partner of E2F. Oncogene 1995, 10:2085-2093.
15. Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, et al.: A new component of the transription factor DRTF1/E2F. Nature 1993, 362:83-87.
16. Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, et al.: Heterodimerisation of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev 1993, 7:1850-1861.
17. Ormondroyd E, de la Luna S, La Thangue NB: A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 1995, 11:1437-1446.
18. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchanblaum F, Fuchs CS, et al.: Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 1992, 70:351-364.
19. Shan B, Zhu X, Chen PL, Durfee T, Yang Y, Sharp D, et al.: Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 1992, 12:5620-5631.
20. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC: Cloning and characterisation of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 1993, 13:7802-7812.
21. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, et al.: The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993, 13:7813-7825.
22. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R: E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 1994, 8:2680-2690.
23. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Cu G, Wydner KL, et al.: E2F-4, a new member of the E2F transcription factor, interacts with p107. Genes Dev 1994, 8:2665-2679.
24. Hymans EM, Voorhoeve PM, Beijersbergen RL, van't Veer LJ, Bernards R: E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 1995, 15:3082-3089.
25. Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M, Helin K: Analysis of p107 associated proteins: p107 associates with a form of E2F that differs from pRb associated E2F-1. J Virol 1993, 67:7641-7647.
26. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 9:1149-1163.
27. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 1993, 366:704-707.
28. Guan K, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, et al.: Growth suppression by p18, a p16- and p14-related cdk6 inhibitor, correlates with wild type pRb function. Genes Dev 1994, 8:2939-2952.
29. INK4b is a potential effector of cell cycle arrest mediated by TGF-β. Nature 1994, 371:257-261.
30. Chan FKM, Zhang J, Chen L, Shapiro DN, Winoto A: Identification of human/mouse p19, a novel cdk4/cdk6 inhibitor with homology to p16. Mol Cell Biol 1995, 15:2682-2688.
31. Hirai H, Roussel MF, Kato J, Ashmun RA, Sherr CJ: Novel INK4 proteins, p18 and p19, are specific inhibitors of cyclin D-dependent kinases cdk4 and cdk6. Mol Cell Biol 1995, 15:2672-2681.
32. Parry D, Bates S, Mann DJ, Peters G: Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16 tumor suppressor gene product. EMBO J 1995, 14:503-511.
33. El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
34. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, et al.: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995, 6:387-400.
35. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704.
36. KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition with cell cycle arrest. Genes Dev 1994, 8:9-22.
37. KIP1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular mitogenic signals. Cell 1994, 78:59-66.
38. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 1994, 78:67-74.
39. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649.
40. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995, 9:650-662.
41. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, et al.: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995, 6:387-400.
42. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, et al.: Retinoblastoma protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 1995, 375:503-506.
43. Schneider JF, Fisher F, Goding CR, Jones NC: Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation. EMBO J 1987, 6:2053-2060.
44. Riley TEW, Follin A, Jones NC, Jat PS: Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1. Mol Cell Biol 1990, 10:6664-6673.
45. Davies R, Hicks R, Crook T, Morris JDH, Vousden KH: Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 1993, 67:2521-2528.
46. Lam EWF, Morris JDH, Davies R, Crook T, Watson RJ, Vousden KH: HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 1994, 13:871-878.
47. Cress WD, Johnson DG, Nevins JR: A genetic analysis of the E2F-1 gene distinguishes regulation by Rb, p107 and adenovirus E4. Mol Cell Biol 1993, 13:6314-6325.
48. Zhang H, Xiong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 1993, 4:897-906.
49. Flores-Rozas H, Kelman Z, Dean FB, Pan Z-Q, Harper JW, Elledge SJ, et al.: Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by DNA polymerase δ holoenzyme. Proc Natl Acad Sci USA 1994, 91:8655-8659.
50. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994, 369:574-578.
51. DeGregori J, Kowalik T, Nevins JR: Cellular targets for activation by the E2F-1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995, 15:4215-4224.
52. Resnitzky D, Reed SI: Different roles for cyclins D1 and E in regulation of the G1 to S transition. Mol Cell Biol 1995, 15:3463-3469.
53. Lukas J, Müller H, Bartkova J, Spitkovsky D, Kjerullf AA, Jansen-Dürr P, et al.: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function. J Cell Biol 1994, 125:625-638.
54. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M: Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994, 9:2663-2674.
55. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Read SI: Human cyclin E, a nuclear protein essential for the G1 to S transition. Mol Cell Biol 1995, 15:2612-2624.
56. DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR: E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 1995, 9:2873-2887.
57. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG, Livingston DM: Negative regulation of the growth promoting transcription factor E2F-1 by a stably bound cyclin-A-dependent protein kinase. Cell 1994, 78:161-172.
58. Dynlacht BD, Flores O, Lees JA, Harlow E: Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 1994, 8:1772-1786.
59. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284.
60. Hall M, Peters G: Genetic alterations of cyclins, cyclin dependent kinases and cdk-inhibitors in human cancer. Adv Cancer Res 1995, 68: in press.
61. Jat PS, Sharp PA: Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol Cell Biol 1989, 9:1672-1681.
62. Xu G, Livingston DM, Krek W: Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 1995, 92:1357-1361.
63. Morganstern JP, Land H: A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 1990, 18:106.
64. Flint KJ, Jones NC: Differential regulation of three members of the ATF/Creb family of DNA-binding proteins. Oncogene 1991, 6:2019-2026.
65. Sleigh MJ: A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells.Anal Biochem 1986, 156:251-256.
66. Harshman KD, Moye-Rowley WS, Parker CS: Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4. Cell 1988, 53:321-330.
67. Harlow E, Lane D: Antibodies, 3rd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1988.